CytoMed Therapeutics Ltd（GDTC）價格預測GDTCCytoMed Therapeutics Ltd

Alphio's GDTC stock price prediction model matches the current CytoMed Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (-0.18%). The 1-week path is $0.84 (-2.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

CytoMed Therapeutics Ltd (GDTC) is not a good buy right now due to its poor financial performance and negative momentum indicators. The current price is $0.86, with a 52-week high of $2.29, indicating a significant drop of 62.4%. Additionally, the RSI is at 31.414, suggesting that the stock is oversold, but this does not guarantee a rebound. The gross margin has improved to 87.51%, but the company continues to report negative net income, with a loss of -885,226 SGD in the latest quarter. The main risk is the declining stock price, which has dropped 56.4% over the past year, indicating ongoing challenges for the company.

CytoMed Therapeutics Ltd (GDTC) last closed at $0.859, losing -2.39%. These facts feed the 1-day and 1-week GDTC price prediction above.